DESCRIPTION• Production of a chimeric antigen receptor (CAR) used for injecting a humanized DR4 antibody gene having apoptosis-inducing activity into a cancer cell-killer T cell • Securing basic technology for the development of dual-acting CAR-T immune cell therapy using CAR-T cell with DR4-specific CAR Features & ContactSign in and you'll be able to send enquiries about this item, view full details and save it
|